Allogene Therapeutics Inc (ALLO) returns
Allogene Therapeutics returns over 5 years
$1,000 invested in Allogene Therapeutics five years ago was worth $68.44 at the close on October 30, 2026, with dividends reinvested: an average return of -41.5% a year. The same $1,000 in the S&P 500 (SPY) became $1,760.
Total return by period
| Period | Total return | A year, on average | $1,000 became | S&P 500 (SPY) |
|---|---|---|---|---|
| 1 month | -26.3% | — | $737.50 | -0.9% |
| 3 months | -40.1% | — | $598.99 | +2.1% |
| Year to date | -13.9% | — | $861.31 | +11.7% |
| 1 year | -2.5% | — | $975.21 | +12.4% |
| 3 years | -57.2% | -24.7% | $427.54 | +88.5% |
| 5 years | -93.2% | -41.5% | $68.44 | +76.0% |
Allogene Therapeutics return by calendar year
| Year | ALLO | S&P 500 (SPY) | Difference |
|---|---|---|---|
| 2026 to date | -13.9% | +11.7% | -25.6% |
| 2025 | -35.7% | +17.7% | -53.4% |
| 2024 | -33.6% | +24.9% | -58.5% |
| 2023 | -49.0% | +26.2% | -75.2% |
| 2022 | -57.8% | -18.2% | -39.7% |
| 2021 | -40.9% | +28.7% | -69.6% |
| 2020 | -2.8% | +18.4% | -21.2% |
| 2019 | -3.5% | +31.2% | -34.7% |
Past returns do not predict future returns. Returns are computed from our daily closes, adjusted for splits and with dividends reinvested on their ex-dates; taxes and trading costs are left out.
See also: ALLO financials
No forecast, no recommendation. This page describes Allogene Therapeutics Inc from published data; it is not advice to buy, sell or hold any security.
Figures as of the close on Oct 30, 2026 unless a row says otherwise. Prices are split adjusted; returns include dividends reinvested. Data may be delayed. See the disclaimer and how TrendArc works.